Cargando…

Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor

Primary carcinoid tumor of the kidney is an extremely rare well-differentiated neuroendocrine tumor, which is generally a low-grade malignant cancer with a good prognosis. Carcinoid tumors are rarely found in the urinary system. Here, we report a 34-year-old woman with primary renal well-differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hua, Zhang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153994/
https://www.ncbi.nlm.nih.gov/pubmed/35655605
http://dx.doi.org/10.2147/OTT.S364545
_version_ 1784717948104998912
author Jiang, Hua
Zhang, He
author_facet Jiang, Hua
Zhang, He
author_sort Jiang, Hua
collection PubMed
description Primary carcinoid tumor of the kidney is an extremely rare well-differentiated neuroendocrine tumor, which is generally a low-grade malignant cancer with a good prognosis. Carcinoid tumors are rarely found in the urinary system. Here, we report a 34-year-old woman with primary renal well-differentiated neuroendocrine tumor who underwent nephron sparing surgery and no evidence of recurrence or distant metastasis was found during routine follow-up. We searched the case of renal carcinoid with the search phrase “carcinoid [title] and kidney [title]” and “carcinoid [title] and renal [title]” using the PubMed and restricted the search to articles published in English since 2013. The clinical manifestations, age, sex, tumor size, location, gross pathology, light microscopy and immunohistochemistry were analyzed. A total of 28 cases of renal carcinoid were retrieved from PubMed. Higher proportion of positive labeling of CgA, Syn, NSE and CD56 are most valuable in the diagnosis of primary renal well-differentiated neuroendocrine tumor. At present, radical nephrectomy remains the gold standard in the curative-intent therapy for well-differentiated neuroendocrine carcinoma of kidney, in metastatic renal carcinoid, long-term use of octreotide may be an effective adjuvant therapy.
format Online
Article
Text
id pubmed-9153994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-91539942022-06-01 Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor Jiang, Hua Zhang, He Onco Targets Ther Case Report Primary carcinoid tumor of the kidney is an extremely rare well-differentiated neuroendocrine tumor, which is generally a low-grade malignant cancer with a good prognosis. Carcinoid tumors are rarely found in the urinary system. Here, we report a 34-year-old woman with primary renal well-differentiated neuroendocrine tumor who underwent nephron sparing surgery and no evidence of recurrence or distant metastasis was found during routine follow-up. We searched the case of renal carcinoid with the search phrase “carcinoid [title] and kidney [title]” and “carcinoid [title] and renal [title]” using the PubMed and restricted the search to articles published in English since 2013. The clinical manifestations, age, sex, tumor size, location, gross pathology, light microscopy and immunohistochemistry were analyzed. A total of 28 cases of renal carcinoid were retrieved from PubMed. Higher proportion of positive labeling of CgA, Syn, NSE and CD56 are most valuable in the diagnosis of primary renal well-differentiated neuroendocrine tumor. At present, radical nephrectomy remains the gold standard in the curative-intent therapy for well-differentiated neuroendocrine carcinoma of kidney, in metastatic renal carcinoid, long-term use of octreotide may be an effective adjuvant therapy. Dove 2022-05-27 /pmc/articles/PMC9153994/ /pubmed/35655605 http://dx.doi.org/10.2147/OTT.S364545 Text en © 2022 Jiang and Zhang. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Jiang, Hua
Zhang, He
Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
title Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
title_full Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
title_fullStr Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
title_full_unstemmed Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
title_short Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
title_sort clinical and pathological features of primary renal well-differentiated neuroendocrine tumor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153994/
https://www.ncbi.nlm.nih.gov/pubmed/35655605
http://dx.doi.org/10.2147/OTT.S364545
work_keys_str_mv AT jianghua clinicalandpathologicalfeaturesofprimaryrenalwelldifferentiatedneuroendocrinetumor
AT zhanghe clinicalandpathologicalfeaturesofprimaryrenalwelldifferentiatedneuroendocrinetumor